p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity?
- PMID: 18854945
- PMCID: PMC11131440
- DOI: 10.1007/s00018-008-8336-3
p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity?
Abstract
For 25 years, the p53 tumor suppressor protein was considered the only protein expressed by the (TP53) gene. However, in several studies the existence of p53 alternative transcripts in mouse and human cells has been documented, while their expression patterns and functions remained a mystery. Since 2002, several groups have identified and described the existence of up to 10 p53 isoforms and have demonstrated their roles in modulation of p53 suppressive activity. It is now clear that the patterns of p53 expression are much more complex than previously recognized and that these isoforms have the potential to act either synergistically or antagonistically, depending on their structure and mechanism of production. This review focuses on the different ways to produce p53 isoforms, on their specific properties, on their effect on p53 suppressive activity as well as on their implication in a new potential mechanism involved in p53 deregulation in cancer.
Similar articles
-
Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.Cell Cycle. 2017 Apr 3;16(7):660-664. doi: 10.1080/15384101.2017.1288327. Epub 2017 Feb 6. Cell Cycle. 2017. PMID: 28166445 Free PMC article.
-
Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.PLoS One. 2014 Aug 8;9(8):e104444. doi: 10.1371/journal.pone.0104444. eCollection 2014. PLoS One. 2014. PMID: 25105592 Free PMC article.
-
Regulation of human p53 activity and cell localization by alternative splicing.Mol Cell Biol. 2004 Sep;24(18):7987-97. doi: 10.1128/MCB.24.18.7987-7997.2004. Mol Cell Biol. 2004. PMID: 15340061 Free PMC article.
-
The p53 mutation "gradient effect" and its clinical implications.J Cell Physiol. 2007 Nov;213(2):370-3. doi: 10.1002/jcp.21217. J Cell Physiol. 2007. PMID: 17671971 Review.
-
The regulation of MDM2 oncogene and its impact on human cancers.Acta Biochim Biophys Sin (Shanghai). 2014 Mar;46(3):180-9. doi: 10.1093/abbs/gmt147. Epub 2014 Jan 3. Acta Biochim Biophys Sin (Shanghai). 2014. PMID: 24389645 Free PMC article. Review.
Cited by
-
p53, a translational regulator: contribution to its tumour-suppressor activity.Oncogene. 2015 Oct 29;34(44):5513-23. doi: 10.1038/onc.2015.25. Epub 2015 Mar 2. Oncogene. 2015. PMID: 25728674 Review.
-
Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets.Nucleic Acids Res. 2011 Mar;39(5):1919-32. doi: 10.1093/nar/gkq1044. Epub 2010 Nov 10. Nucleic Acids Res. 2011. PMID: 21071400 Free PMC article.
-
Aberrant alternative splicing is another hallmark of cancer.Int J Cell Biol. 2013;2013:463786. doi: 10.1155/2013/463786. Epub 2013 Sep 11. Int J Cell Biol. 2013. PMID: 24101931 Free PMC article. Review.
-
Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor.Biosci Rep. 2013 Jul 25;33(4):e00054. doi: 10.1042/BSR20130065. Biosci Rep. 2013. PMID: 24003888 Free PMC article. Review.
-
p53 protein isoforms: key regulators in the front line of pathogen infections?PLoS Pathog. 2013;9(4):e1003246. doi: 10.1371/journal.ppat.1003246. Epub 2013 Apr 4. PLoS Pathog. 2013. PMID: 23592981 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous